Barely Significant
← all excerpts

Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome.

J Pharmacol Pharmacother · 2015 · PMC4544133 · PMID 26311995

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
Atorvastatin 40 mg treatment caused highly significant decline ( P < 0.001) in CRP levels in group A at the end of treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.